Castor
Private Company
Total funding raised: $45M
Overview
Founded in 2012, Castor has established itself as a leading provider of a modern, cloud-based eClinical platform designed to simplify and accelerate clinical research. The company offers a comprehensive, integrated suite for data capture, patient-reported outcomes, consent, and trial management, targeting efficiency gains and improved patient experiences. As a private company, it caters to a broad market from large biopharma to academic institutions, capitalizing on the industry's shift towards decentralized and digitized trials. Its value proposition centers on user-friendliness, rapid deployment, and robust compliance with global regulatory standards.
Technology Platform
Integrated cloud-based electronic clinical data management platform combining EDC, ePRO/eCOA, eConsent, IWRS, eSource, CDMS, and decentralized trial solutions in a single system.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes in the crowded eClinical software market against large established players like Medidata (a Dassault Systèmes company), Veeva Systems, and Oracle, as well as other EDC and DCT-focused vendors such as Clinion, Medrio, and Clinical Conductor. Differentiation is based on user-friendliness, integrated platform approach, and rapid deployment.